Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals

Human Immunology

Volumn 71, Issue 2, 2010, Pages 123-127

  Hashimoto, Masao ^a   Kitano, Mitsutaka ^a   Honda, Kazutaka ^a   Koizumi, Hirokazu ^a   Dohki, Sachi ^a   Oka, Shinichi ^a,b   Takiguchi, Masafumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Cytotoxic; Epitopes; Escape mutation; HIV 1; HLA B*5401; T lymphocytes

Indexed keywords

EPITOPE; HLA B ANTIGEN; MUTANT PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CELL KILLING; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPANESE; MUTANT; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TARGET CELL; WILD TYPE;

CHRONIC DISEASE; EPITOPES, T-LYMPHOCYTE; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; MUTATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 74449091083     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.10.015     Document Type: Article

References (27)

1. Ogg G.S., Jin X., Bonhoeffer S., Dunbar P.R., Nowak M.A., Monard S., et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279 (1998) 2103-2106
2. Goulder P.J., and Watkins D.I. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8 (2008) 619-630
3. Goulder P.J., Phillips R.E., Colbert R.A., McAdam S., Ogg G., Nowak M.A., et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3 (1997) 212-217
4. Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 3 (1997) 205-211
5. Price D.A., Goulder P.J., Klenerman P., Sewell A.K., Easterbrook P.J., Troop M., et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 94 (1997) 1890-1895
6. Kelleher A.D., Long C., Holmes E.C., Allen R.L., Wilson J., Conlon C., et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 193 (2001) 375-386
7. Fujiwara M., Tanuma J., Koizumi H., Kawashima Y., Honda K., Mastuoka-Aizawa S., et al. Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts. J Virol 82 (2008) 138-147
8. Goulder P.J., and Watkins D.I. HIV and Siv CTL escape: implications for vaccine design. Nat Rev Immunol 4 (2004) 630-640
9. Barouch D.H., and Letvin N.L. HIV escape from cytotoxic T lymphocytes: a potential hurdle for vaccines?. Lancet 364 (2004) 10-11
10. Walker B.D., and Korber B.T. Immune control of HIV: the obstacles of HLA and viral diversity. Nat Immunol 2 (2001) 473-475
11. McMichael A.J., and Rowland-Jones S.L. Cellular immune responses to HIV. Nature 410 (2001) 980-987
12. Feeney M.E., Tang Y., Roosevelt K.A., Leslie A.J., McIntosh K., Karthas N., et al. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J Virol 78 (2004) 8927-8930
13. + T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 79 (2005) 13239-13249
14. + T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors. J Virol 83 (2009) 88-97
15. Frater A.J., Brown H., Oxenius A., Günthard H.F., Hirschel B., Robinson N., et al. Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol 81 (2007) 6742-6751
16. Brumme Z.L., Brumme C.J., Carlson J., Streeck H., John M., Eichbaum Q., et al. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 82 (2008) 9216-9227
17. Schneidewind A., Brockman M.A., Sidney J., Wang Y.E., Chen H., Suscovich T.J., et al. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J Virol 82 (2008) 5594-5605
18. Schneidewind A., Brockman M.A., Yang R., Adam R.I., Li B., Le Gall S., et al. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol 81 (2007) 12382-12393
19. Imanishi T., Akaza T., Kimura A., Tokunaga K., and Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K., Aizava M., and Sasazuki T. (Eds). HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference (1992), Oxford University Press, Oxford 1065-1220
20. Kitano M., Kobayashi N., Kawashima Y., Akahoshi T., Nokihara K., Oka S., et al. Identification and characterization of HLA-B* 5401-restricted HIV-1-Nef and Pol-specific CTL epitopes. Microbes Infect 10 (2008) 764-772
21. Gatanaga H., Hachiya A., Kimura S., and Oka S. Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure. Virology 344 (2006) 354-362
22. + T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. J Virol 83 (2009) 1845-1855
23. Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10 (2004) 282-289
24. Davenport M.P., Loh L., Petravic J., and Kent S.J. Rates of HIV immune escape and reversion: implications for vaccination. Trends Microbiol 16 (2008) 561-566
25. Koizumi H., Iwatani T., Tanuma J., Fujiwara M., Izumi T., Oka S., et al. Escape mutation selected by Gag28-36-specific cytotoxic T cells in HLA-A*2402-positive HIV-1-infected donors. Microbes Infect 11 (2009) 198-204
26. Furutsuki T., Hosoya N., Kawana-Tachikawa A., Tomizawa M., Odawara T., Goto M., et al. Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population. J Virol 78 (2004) 8437-8445
27. McMichael A.J. Triple bypass: complicated paths to HIV escape. J Exp Med 204 (2007) 2785-2788